Treatment for Post-Mastectomy Pain Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Post-Mastectomy Pain Syndrome
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial will evaluate a new surgical approach to treating post-mastectomy pain caused by nerve damage. The hope is that this will improve patients' quality of life.

Eligible Conditions
  • Post-Mastectomy Pain Syndrome

Treatment Effectiveness

Study Objectives

5 Primary · 0 Secondary · Reporting Duration: Baseline to 12 - 24 months

Month 24
Change in depression/anxiety scores
Change in opioid consumption
Change in pain level
Up to 24 months
Freedom from neuroma recurrence evaluated by physical exam
Freedom from neuroma recurrence evaluated by ultrasound

Trial Safety

Trial Design

0 Treatment Group

25 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 12 - 24 months

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,069 Previous Clinical Trials
41,129,383 Total Patients Enrolled
University of Michigan Rogel Cancer CenterLead Sponsor
267 Previous Clinical Trials
18,106 Total Patients Enrolled
David L Brown, M.D.Principal InvestigatorUniversity of Michigan

Eligibility Criteria

Age 18+ · Female Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: